Učitavanje...
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
Although there are molecularly distinct subtypes of prostate cancer, no molecular classification system is used clinically. The ribonucleotide reductase small subunit M2 (RRM2) gene plays an oncogenic role in many cancers. Our previous study elucidated comprehensive molecular mechanisms of RRM2 in p...
Spremljeno u:
| Izdano u: | Mol Oncol |
|---|---|
| Glavni autori: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7400792/ https://ncbi.nlm.nih.gov/pubmed/32385899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12706 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|